Comment

Preventing Cervical Cancer with Digital Health

June 28, 2023
Comment

Preventing Cervical Cancer with Digital Health

June 28, 2023

This is some text inside of a div block.
mins read
Speaker shot.

Speaker shot.

Speaker shot.

In England alone, around 2,700 women are diagnosed with cervical cancer each year. However, the NHS screening programme saves approximately 5,000 lives annually. Sadly, 850 women still lose their lives to cervical cancer every year. 83% of these deaths could be avoidable if all eligible women participated in their screenings, potentially saving 706 lives.

Screening programmes play a pivotal role in early detection and prevention of cervical cancer. By employing highly effective tests to check for high-risk human papillomavirus (HPV), which is found in over 99% of all cervical cancers, screenings can identify abnormal cells in the cervix. These abnormal cells, if left untreated, can develop into cancer over time.

Through [the project commissioned by NHS England and North of England CSU], attendance rates for cervical cancer screenings increased by 6.3% in London. The project reduced the invite-to-appointment time by 17 days.

Increasing screening attendance with digital health technology

One remarkable success story in promoting cervical cancer screenings is the project commissioned by NHS England and North of England CSU. The project used iPLATO's Population Health Service to send text message reminders to women who were due for their screening appointment. Through this initiative, attendance rates for cervical cancer screenings increased by 6.3% in London. The project reduced the invite-to-appointment time by 17 days. We are proud that iPLATO, part of the Huma family, was nominated for the 2023 HSJ Digital Awards for this exceptional work.

Saving costs for the NHS

The financial and human impact of cervical cancer cannot be ignored. The average cost to the NHS for treating an individual diagnosed with stage 2 cervical cancer or later is £19,261. In contrast, for those diagnosed at stage 1a, the cost drops significantly to around £1,379 per person. By implementing simple interventions such as text message reminders, we can bridge the gap between individuals receiving timely treatment and the NHS saving thousands of pounds in treating patients with late-stage cervical cancer.

Seamless connectivity and efficient healthcare

At Huma, our vision encompasses a healthcare system where an individual’s health and social care information is seamlessly connected and easily navigable. By enabling clinicians and care providers to access a complete picture of a person's health history, we can efficiently manage population health using valuable data. Through the integration of digital health technologies, we can create a future where preventive care and early detection are prioritised, leading to better health outcomes for all.

Screening is a powerful tool in preventing cervical and other cancers. By leveraging digital health solutions and innovative projects like those supported by iPLATO, we can significantly increase screening attendance rates and save lives. Let's continue to raise awareness, use technology for good, and create a connected healthcare system that prioritises preventive care. Together, we can transform cervical cancer prevention and ensure a healthier future for women all over the world.

Contact us to discover more

This field is required
Email must be formatted correctly
This field is required
This field is required
This field is required

Huma is committed to respecting your privacy, we’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. You can unsubscribe at any time. Review our Privacy Policy for further information.

Keep up to date on our current work and research with the latest marketing updates from Huma, including monthly news, events and communications on products and services.

By clicking submit below, you consent to allow Huma to store and process the personal information submitted above to provide you the content requested.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

This field is required
This field is required
This field is required
This field is required
Thank you for your request.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form

Email must be formatted correctly
This field is required
This field is required
This field is required
This field is required
This field is required
Country/Region*
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

You’re in control. You can, of course, withdraw your consent at any time. Review our Privacy Policy for further information.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

Making an impact

3000+

3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1

×2

Our platform can almost double clinical capacity and reduce readmission rates by >30%3

27m+

Huma's digital-first health platforms support a network of 27m patients1

1m+

Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Sources:

Comment

Preventing Cervical Cancer with Digital Health

June 28, 2023
Comment

Preventing Cervical Cancer with Digital Health

June 28, 2023

Huma joins digital pioneers to advance health equity in care and research

Chief Executive Officer and Founder, Dan Vahdat, is returning to the annual World Economic Forum’s main conference where he will join a panel discussion devoted to improving care for non-communicable disease and tackling health equity. Accompanied by Chief Financial and Strategy Officer, Ingeborg Oie, Dan is looking forward to connecting with other attendees to explore how Huma’s digital health platform can make healthcare more equitable, and advances proactive, predictive care.

Huma joins digital pioneers to advance health equity in care and research

Date:Wednesday, January 18, 2023
Time:4:15 - 5:15 p.m. CET
Location:Ice Village, Eisbahnstrasse 5, Davos, Switzerland
Dan will join the Digital Health Action Alliance panel at Davos to discuss Turning the Tide in Non-Communicable Disease Care Through Digital Health and Community Connection. Huma has a long history of advancing the care of non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and lung conditions. Huma’s innovative remote patient monitoring platform enables broad patient recruitment, reduces reliance on in-person clinic visits and increases health system efficiency.
*This session is open to registered Annual Meeting 2023 participants and Affiliate badge holders.

Huma is one of the first to sign the Zero Health Gaps Pledge

Huma is one of the first signatories to the Zero Health Gaps Pledge, the World Economic Forum’s Global Health Equity Network’s (GHEN) initiative. Huma supports GHEN’s ambition to build a future without disparities in health or wellbeing outcomes. Huma’s digital platform has been built on a deep clinical knowledge of complex patient needs and how people engage with technology and we are committed to ensuring our technology promotes health equity. We are proud to work with governments, hospital groups, universities, life science and technology companies to bring greater scale and impact and help all people live longer, fuller lives.

Huma at World Economic Forum

Global Innovators and Tech Pioneers
Dec 2022: Huma selected to join 100 innovative companies on a two-year journey as part of the World Economic Forum’s initiatives, activities and events, bringing their cutting-edge insight and fresh thinking to critical global discussions.
Learn more
Working Together, Restoring Trust
May 2022: With the aim to address economic, environmental, political, and social fault-lines exacerbated by the COVID-19 pandemic, Dan Vahdat speaks at WEF annual meeting about the importance of scientific collaboration.
Learn more
Accelerating innovation and breaking new ground
October 2022: Dan joined the WEF Biotech Future Forum 2022 to discuss how start-ups are breaking new ground in biotech and changing the way we interact with the world, but also how the sector can earn trust, scale successfully and spot the brightest innovations.
Learn more
Making connections at Davos
Jan 2019: Dan attended WEF as an unofficial attendee and spoke to CNBC about the importance of meeting in-person to make connections.
Learn more

Related Articles

See more
Article
AI is in our DNA
Explore how Huma has been developing AI to revolutionise healthcare, and request a meeting with us to find out more.
Learn more
Article
“It’s really gold dust” Why Huma is a big step forward for knee surgery
Discover how Huma is providing Smith+Nephew with real world evidence for robotic knee replacement surgery.
Learn more

Related Blogs

See more
Blog
The benefits of using an app to manage gestational diabetes: Niki’s story
Learn more
Blog
How Huma is transforming Health
Tim Broke-Smith, Huma's Vice President, Global Pharma Partnerships, considers how cutting edge technology can transform healthcare.
Learn more

Related Ebooks

See more
Ebook
Welcome to next-generation digital-first care and research
Deliver more personalised digital-first care and research with the first disease agnostic enterprise platform to achieve EU MDR Class IIb certification1.
Learn more
Ebook
What does FDA 510(k) Class II mean for Huma and our partners
Deliver more personalised digital-first care and research with our enterprise platform which now has FDA 510 (K) Class II clearance for any physician-specified condition.
Learn more

Related White Papers

See more
White Paper
Navigating the DCT transition
Learn how remote trial technology is changing the clinical trial landscape and key considerations when including DCT components in your study protocols.
Learn more
Comment

Preventing Cervical Cancer with Digital Health

June 28, 2023
Media contact
Comment

Preventing Cervical Cancer with Digital Health

June 28, 2023
Media contact

In England alone, around 2,700 women are diagnosed with cervical cancer each year. However, the NHS screening programme saves approximately 5,000 lives annually. Sadly, 850 women still lose their lives to cervical cancer every year. 83% of these deaths could be avoidable if all eligible women participated in their screenings, potentially saving 706 lives.

Screening programmes play a pivotal role in early detection and prevention of cervical cancer. By employing highly effective tests to check for high-risk human papillomavirus (HPV), which is found in over 99% of all cervical cancers, screenings can identify abnormal cells in the cervix. These abnormal cells, if left untreated, can develop into cancer over time.

asdasd

asda

asdsads

asda

asdsad

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Download
Share this
COMPANY

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more